The NIH says funding cuts would save it billions of dollars a year. D.C.-area industry and academic leaders say it would cripple R&D.

Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...

Though most biopharma investment is in two states, follow this model to bring the research—and investments—elsewhere.

Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication. However, viruses are dynamic ...

Researchers have introduced genetic material into plants via their roots, opening a potential pathway for rapid crop improvement.

Content oversight and quality assurance provided by Studio 1847 Health care-associated infections pose a persistent and tremendous threat to patient safety. According to the Centers for Disease ...

Researchers from the Fraunhofer Institute for Process Engineering and Packaging (IVV) and Albstadt-Sigmaringen University ...